D-1499-2016 Class II Terminated
FDA drug recall D-1499-2016 was initiated by Aurobindo Pharma USA Inc on Aug 3, 2016 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole. The recall status is terminated (terminated Jun 8, 2018). Affected quantity: 23016 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 21, 2016
- Initiation Date
- Aug 3, 2016
- Termination Date
- Jun 8, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23016 bottles
Product description
Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90
Reason for recall
Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.
Distribution pattern
CA
Code information
PSSB16011-A, Exp 01/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1499-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026